ClinicalTrials.gg
RecruitingNCT07860996Updated Oct 13, 2026

Total Intravenous Versus Inhalational Anesthesia in Patients Undergoing Hip Fracture Surgery

An observational study in Hip Fracture and Postoperative Recovery, sponsored by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · Observational

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Oct 13, 2026Primary outcomes revisedNewly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
110
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 78 studies in Hip Fractures with a site in Turkey — 14 open to participants now, 18 under way, none of them phase 3. Hip Fractures · Turkey.

Planned enrollment
14th of 40
110 · median 98
Started
2026
with 10 others
Observational
40 of 78
9 open now
Primary completion
2027-03
later than 15 of 17 live
Registered
78th of 78
by date
Lead sponsor
3 of 78
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Among the 78 studies in Hip Fractures with a site in Turkey, this one is the 14th largest by planned enrollment of the 40 observational ones that give a count, is one of 11 that started in 2026, is one of 40 observational ones, reaches primary completion later than 15 of the 17 other live ones, and was the 78th registered.

Hip Fractures

843 studies on the registry are indexed under Hip Fractures; 166 are open to participants now.

Browse Hip Fractures studies →

Open to participants now

14 of the 78 studies in Hip Fractures with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 104 Hip Fractures studies recruiting now, 82 (79%) set no upper age limit and 6 (6%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 78 studies in Hip Fractures with a site in Turkey, or all of them as a file.
02

Study summary

This prospective observational study aims to compare total intravenous anesthesia (TIVA) with sevoflurane-based inhalational anesthesia in patients aged 65 years and older undergoing hip fracture surgery under general anesthesia. The study will evaluate postoperative quality of recovery using the Quality of Recovery-40 (QoR-40) questionnaire and cognitive outcomes, including postoperative delirium and cognitive status. Pain scores, opioid consumption, recovery room stay, postoperative complications, and patient satisfaction will also be recorded. The anesthesia technique will be determined by the attending anesthesiologist as part of routine clinical practice, and the researchers will not interfere with the choice of anesthesia.

Read the detailed description

This is a prospective, single-center observational study involving patients aged 65 years and older who undergo hip fracture surgery under general anesthesia. Patients will be followed according to the anesthesia technique used during routine clinical care: propofol-based total intravenous anesthesia (TIVA) or sevoflurane-based inhalational anesthesia. No intervention or modification of routine anesthesia management will be performed by the investigators.

Demographic characteristics, ASA physical status, comorbidities, preoperative Quality of Recovery-40 (QoR-40) scores, and Mini-Mental State Examination (MMSE) scores will be recorded. Intraoperative data, including anesthesia and surgery duration, hemodynamic parameters, extubation time, and anesthetic and analgesic drug consumption, will also be collected.

On postoperative day 1, QoR-40, numerical rating scale (NRS) pain scores, and postoperative delirium using the 3D-CAM will be assessed. On postoperative day 2, QoR-40 and pain assessments will be repeated, and postoperative opioid consumption, post-anesthesia care unit stay, complications, and patient satisfaction will be recorded. Postoperative questionnaires and cognitive assessments will be performed by an investigator blinded to the anesthesia technique.

03

Conditions studied

  • Hip Fracture
  • Postoperative Recovery

Keywords

  • TIVA
  • Inhalational Anesthesia
  • Quality of Recovery-40 (QoR-40)
  • Postoperative Delirium
  • Cognitive Function
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged 65 years or older undergoing hip fracture surgery under general anesthesia at Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital. Participants will be observed according to the anesthesia technique used as part of routine clinical practice: propofol-based total intravenous anesthesia or sevoflurane-based inhalational anesthesia.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 65 years or older
  • I-III
  • Scheduled to undergo elective or emergency hip fracture surgery under general anesthesia
  • Provision of by the patient and/or legal representative

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study
  • IV-V
  • Severe pre-existing neurological or psychiatric disorders, including advanced dementia or severe cognitive impairment preventing communication
  • Known or allergy to propofol or sevoflurane
  • History of chronic heavy opioid or sedative substance use
  • Inability to communicate in Turkish or to understand and complete the QoR-40 questionnaire
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
110 participants (estimated)
Patient registry
No

Groups and cohorts

  • TIVA

    Patients undergoing hip fracture surgery under general anesthesia who receive propofol-based total intravenous anesthesia (TIVA) as part of routine clinical care. The anesthesia technique is determined by the attending anesthesiologist, and the investigators do not interfere with treatment selection.

    Other: Propofol-based Total Intravenous Anesthesia

  • Sevoflurane

    Patients undergoing hip fracture surgery under general anesthesia who receive sevoflurane-based inhalational anesthesia as part of routine clinical care. The anesthesia technique is determined by the attending anesthesiologist, and the investigators do not interfere with treatment selection.

    Other: Sevoflurane-based Inhalational Anesthesia

Interventions

  • OtherPropofol-based Total Intravenous Anesthesia

    Propofol-based total intravenous anesthesia administered according to routine clinical practice during hip fracture surgery.

  • OtherSevoflurane-based Inhalational Anesthesia

    Sevoflurane-based inhalational anesthesia administered according to routine clinical practice during hip fracture surgery.

06

What researchers measure

Primary outcomes

  1. Quality of Recovery-40 (QoR-40) Score on Postoperative Day 1

    Postoperative quality of recovery will be assessed using the Quality of Recovery-40 (QoR-40) questionnaire. The QoR-40 consists of 40 items evaluating five dimensions of recovery: physical comfort, emotional state, physical independence, psychological support, and pain. Higher total scores indicate better quality of recovery.The total score ranges from 40 to 200, with higher scores indicating better postoperative recovery.

    Time frame: Postoperative day 1

Secondary outcomes

  1. Quality of Recovery-40 (QoR-40) Score on Postoperative Day 2

    Quality of recovery will be reassessed on postoperative day 2 using the Quality of Recovery-40 (QoR-40) questionnaire. The total score ranges from 40 to 200, with higher scores indicating better postoperative recovery.

    Time frame: Postoperative day 2

  2. Incidence of Postoperative Delirium

    Postoperative delirium will be assessed using the 3D-CAM assessment.

    Time frame: Postoperative day 1

  3. Postoperative Pain Intensity

    Postoperative pain intensity will be evaluated using the Numerical Rating Scale (NRS).

    Time frame: Postoperative days 1 and 2

  4. Postoperative Opioid Consumption

    Total postoperative opioid consumption will be recorded from routine clinical records.

    Time frame: Up to postoperative day 2

  5. Post-Anesthesia Care Unit Length of Stay

    Duration of stay in the post-anesthesia care unit (PACU) will be recorded.

    Time frame: From admission to discharge from the PACU

  6. Incidence of Postoperative Complications

    Postoperative complications occurring during the study observation period will be recorded.

    Time frame: Up to postoperative day 2

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Myles PS, Myles DB, Galagher W, Chew C, MacDonald N, Dennis A. Minimal Clinically Important Difference for Three Quality of Recovery Scales. Anesthesiology. 2016 Jul;125(1):39-45. doi: 10.1097/ALN.0000000000001158. PubMed 27159009 ↗
  • Myles PS, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000 Jan;84(1):11-5. doi: 10.1093/oxfordjournals.bja.a013366. PubMed 10740540 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared publicly due to participant confidentiality and data protection considerations.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Mar 2027, 6 months after the start.

Of 107 non-industry observational studies under Hip Fractures, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 65. This study's planned 6 months is below that.

Counting every sponsor, half of 124 studies reached it within 28 months; a quarter within 12 and three quarters within 83.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2026
First posted
Oct 6, 2026
StartActual
Sep 30, 2026
Primary completionEst.
Mar 30, 2027
CompletionEst.
Mar 30, 2027
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionQuality of Recovery-40 (QoR-40) Score on Postoperative Day 1: how it is measured was reworded
Oct 13, 2026
Secondary outcomes
1 description edited
What changed in the outcomes
  • DescriptionQuality of Recovery-40 (QoR-40) Score on Postoperative Day 2: how it is measured was reworded
Oct 13, 2026
Registered
First appeared on the registry
Oct 6, 2026
Show all 2 updates
  1. Oct 13, 2026
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionQuality of Recovery-40 (QoR-40) Score on Postoperative Day 1: how it is measured was reworded
    Secondary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionQuality of Recovery-40 (QoR-40) Score on Postoperative Day 2: how it is measured was reworded
    + 2 other changes: index terms and conditions
  2. Oct 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07860996
Lead sponsor
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Responsible party
Sponsor
First posted
Oct 6, 2026
Start date
Sep 30, 2026
Primary completion
Mar 30, 2027 (estimated)
Completion
Mar 30, 2027 (estimated)
Last update
Oct 13, 2026

Study contacts

Şule Altuncu Altuncu, MD
Contact
sule.621@hotmail.com
+90 216 606 33 00

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion